Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Non-Alcoholic Fatty Liver Disease and Cardiovascular Comorbidities: Pathophysiological Links, Diagnosis, and Therapeutic Management
Alexandra Jichitu, Simona Bungău, Ana Maria Alexandra Stănescu, et al.
Diagnostics (2021) Vol. 11, Iss. 4, pp. 689-689
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Roles of the peroxisome proliferator-activated receptors (PPARs) in the pathogenesis of nonalcoholic fatty liver disease (NAFLD)
Yuan-ye Qiu, Jing Zhang, Fanyi Zeng, et al.
Pharmacological Research (2023) Vol. 192, pp. 106786-106786
Open Access | Times Cited: 105
Clinical Practice Guidelines of the Russian Scientific Liver Society, Russian Gastroenterological Association, Russian Association of Endocrinologists, Russian Association of Gerontologists and Geriatricians and National Society for Preventive Cardiology on Diagnosis and Treatment of Non-Alcoholic Liver Disease
В. Т. Ивашкин, M. V. Maevskaya, М. С. Жаркова, et al.
Russian Journal of Gastroenterology Hepatology Coloproctology (2022) Vol. 32, Iss. 4, pp. 104-140
Open Access | Times Cited: 47
Effects of the 5:2 intermittent fasting diet on non-alcoholic fatty liver disease: A randomized controlled trial
Hamed Kord‐Varkaneh, Ammar Salehi sahlabadi, Mihnea‐Alexandru Găman, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 43
The National Consensus statement on the management of adult patients with non-alcoholic fatty liver disease and main comorbidities
M. V. Maevskaya, Yu. V. Kotovskaya, В. Т. Ивашкин, et al.
Terapevticheskii arkhiv (2022) Vol. 94, Iss. 2, pp. 216-253
Open Access | Times Cited: 40
New Insights into the Pathogenesis of Metabolic-Associated Fatty Liver Disease (MAFLD): Gut–Liver–Heart Crosstalk
Keungmo Yang, Myeong Jun Song
Nutrients (2023) Vol. 15, Iss. 18, pp. 3970-3970
Open Access | Times Cited: 23
Plants-based medicine implication in the evolution of chronic liver diseases
Monica Foghis, Simona Bungău, Alexa Florina Bungău, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 158, pp. 114207-114207
Open Access | Times Cited: 22
Effects of naringenin supplementation on cardiovascular risk factors in overweight/obese patients with nonalcoholic fatty liver disease: a pilot double-blind, placebo-controlled, randomized clinical trial
Fatemeh Naeini, Zahra Namkhah, Helda Tutunchi, et al.
European Journal of Gastroenterology & Hepatology (2021) Vol. 34, Iss. 3, pp. 345-353
Closed Access | Times Cited: 27
Comorbid flow non-alcoholic fatty liver disease and osteoporosis
Л. А. Фомина
Medical alphabet (2025), Iss. 34, pp. 42-46
Closed Access
Predictive Capacity of Different Indicators of Adiposity for Metabolic Syndrome in Adults in the City of Trujillo, Peru
Jorge Luis Díaz-Ortega, Joao Caballero-Vidal, Irma Luz Yupari-Azabache, et al.
Medicina (2025) Vol. 61, Iss. 3, pp. 419-419
Open Access
Clinical Guidelines of the Russian Society for the Study of the Liver, Russian Gastroenterological Association, Russian Society for the Prevention of Non-Communicable Diseases, Russian Association of Endocrinologists, Russian Scientific Medical Society of Therapists, National Society of Preventive Cardiology, Russian Association of Gerontologists and Geriatricians on Non-Alcoholic Fatty Liver Disease
В. Т. Ивашкин, О. М. Драпкина, M. V. Maevskaya, et al.
Russian Journal of Gastroenterology Hepatology Coloproctology (2025) Vol. 35, Iss. 1, pp. 94-152
Open Access
Dentistry Status Features of Patients with Non-alcoholic Fatty Liver Disease
T. N. Kaisina, С. Н. Громова, Е. П. Колеватых, et al.
Ural Medical Journal (2025) Vol. 24, Iss. 2, pp. 7-20
Closed Access
Repurposing Metformin for the Treatment of Atrial Fibrillation: Current Insights
Aparajita Sarkar, Kareem Fanous, Isra Marei, et al.
Vascular Health and Risk Management (2024) Vol. Volume 20, pp. 255-288
Open Access | Times Cited: 3
Pathophysiological mechanisms of cardiovascular disorders in non-alcoholic fatty liver disease.
Dmitry Victorovich Garbuzenko
PubMed (2022) Vol. 15, Iss. 3, pp. 194-203
Closed Access | Times Cited: 13
Sphingosine kinase 1 mediates sexual dimorphism in fibrosis in a mouse model of NASH
David Montefusco, Maryam Jamil, Melissa A. Maczis, et al.
Molecular Metabolism (2022) Vol. 62, pp. 101523-101523
Open Access | Times Cited: 12
Phenotypes of Non-Alcoholic Fatty Liver Disease in Different Regions of the Russian Federation, Diagnostic and Therapeutic Approach in Clinical Practice
В. Т. Ивашкин, М. С. Жаркова, N. V. Korochanskaya, et al.
Russian Journal of Gastroenterology Hepatology Coloproctology (2023) Vol. 33, Iss. 2, pp. 7-18
Open Access | Times Cited: 7
Influence of MAFLD and NAFLD on arterial stiffness: A longitudinal cohort study
Tae Kyung Yoo, Seung Wook Lee, Mi Yeon Lee, et al.
Nutrition Metabolism and Cardiovascular Diseases (2024)
Closed Access | Times Cited: 2
The mitochondrial translocator protein (TSPO, 18 kDa): A key multifunctional molecule in liver diseases
Yuchang Li, Liting Chen, Vassilios Papadopoulos
Biochimie (2023) Vol. 224, pp. 91-103
Closed Access | Times Cited: 6
Relationship between non-invasively detected liver fibrosis and in-hospital outcomes in patients with acute coronary syndrome undergoing PCI
Flavio Giuseppe Biccirè, Francesco Barillà, Emanuele Sammartini, et al.
Clinical Research in Cardiology (2022) Vol. 112, Iss. 2, pp. 236-246
Open Access | Times Cited: 9
Comorbidities and Malignancy among NAFLD Patients Compared to the General Population, A Nation-Based Study
Naim Abu‐Freha, Bracha Cohen, Michal Gordon, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1110-1110
Open Access | Times Cited: 5
The association between healthy eating index-2015 with anthropometric, cardiometabolic and hepatic indices among patients with non-alcoholic fatty liver disease
Seyed Ahmad Hosseini, Ali Akbar Shayesteh, Seyed Jalal Hashemi, et al.
BMC Gastroenterology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
A Glimpse at the Size of the Fetal Liver—Is It Connected with the Evolution of Gestational Diabetes?
Matei-Alexandru Cozma, Mihnea‐Alexandru Găman, Elena-Codruța Dobrică, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 7866-7866
Open Access | Times Cited: 9
The Crucial Role of Diet Therapy and Selenium on the Evolution of Clinical and Paraclinical Parameters in Patients with Metabolic Syndrome
Adrian Danciu, Timea Claudia Ghitea, Alexa Florina Bungău, et al.
Journal of Nutrition and Metabolism (2023) Vol. 2023, pp. 1-14
Open Access | Times Cited: 3
Health-care provision and policy for non-alcoholic fatty liver disease in sub-Saharan Africa
C. Wendy Spearman, Abdelmounem Abdo, Aggrey Ambali, et al.
˜The œLancet. Gastroenterology & hepatology (2021) Vol. 6, Iss. 12, pp. 1047-1056
Closed Access | Times Cited: 6
Circ_0004535/miR-1827/CASP8 network involved in type 2 diabetes mellitus with nonalcoholic fatty liver disease
Min Li, Ai Zeng, Xinle Tang, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Establishment and evaluation of a risk-prediction model for hypertension in elderly patients with NAFLD from a health management perspective
An Zhang, Xin Luo, Hong Pan, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top